| Source HCPCS Code |
|
Target NDC Code |
J0739
Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv
|
⇄
|
49702-0238-03
APRETUDE ER 600 MG/3 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
J0739
INJECTION, CABOTEGRAVIR, 1MG, FDA APPROVED PRESCRIPTION, ONLY FOR USE AS HIV PRE-EXPOSURE PROPHYLAXIS (NOT FOR USE AS TREATMENT FOR HIV)
|
⇄
|
49702-0264-23
APRETUDE (LATEX-FREE) 200 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
J0739
Hiv prep, cabotegravir, 1mg
|
⇄
|
49702-0264-23
Apretude
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|